Exposure to metal oxide nanoparticles administrated at occupationally-relevant doses induces pulmonary effects in mice, Nanotoxicology,
INTRODUCTION
Atmospheric pollution has long been known to potentially induce adverse health effects in the general population [1] . Particulate pollution represents one component of the atmospheric pollution that is associated with an increased morbidity and mortality, in particular at the cardiovascular and respiratory levels [2] [3] [4] [5] . Nanoparticles (NP) constitute an important and still growing part of particulate pollution not only in the environmental context, but also in occupational settings.
At workplace, NP pollution can be emitted secondary to various industrial processes, such as arc-welding. During this process, welding fumes contain NP that represent up to 10% in mass and 80% in number of the total particles emitted [6] [7] [8] [9] . NP can also be emitted intentionally at workplace, thereby generating manufactured NP. Exposure of workers to NP can occur during the initial production of NP, as well as during their further processing, dispersion and/or integration in secondary products. NP concentrations up to several mg/m 3 have been detected in workplaces manufacturing nanosized iron oxides, titanium dioxide, silver or nanostructured materials used for the electric industry for example [10] [11] [12] [13] [14] .
A growing number of workers is estimated to be involved in work processes linked to the intentional or unintentional production of NP; up to 6 millions of workers will potentially be exposed to NP in 2020 [15] . In spite of the great promises that the development of nanotechnologies can offer, concerns regarding potential adverse health effects of such occupational exposure to NP is raised. However, very few data are currently available, probably because of the relatively recent development of nanotechnologies and production of manufactured NP. On the other hand, NP unintentionally emitted during an occupational activity such as welding is however not new, and we can, as such, take advantage of the literature available on this population of workers. Various adverse respiratory outcomes have been described in welders, among which inflammation and lung remodeling are largely J U S T A C C E P T E D reported [16, 17] . We recently identified metal oxide NP (Fe, Mn, Cr oxides essentially) in lung tissue sections of welders [18] . These metal oxide NP were located inside macrophages present in the alveolar lumen and infiltrated in fibrous regions, which suggests a role for these NP in the lung alterations observed in welders.
To deepen our findings and extend them to occupational settings where NP are intentionally emitted, we designed an in vivo study aimed to investigate the pulmonary effects, in mice, of repeated exposure to NP administrated at occupationally-relevant doses. Our underlying hypothesis was that repeated exposure to NP at occupational levels could lead to lung remodeling similar to that observe in lung tissue from welders. Therefore, 4 metal oxide NP in relationship with the occupational exposure of welding, and that we previously identified in lung tissue sections from welders [18] were chemically synthetized and characterized as powder and as suspension after sonication as previously described [18] . Stock solutions of NP suspensions (2 mg/mL) were prepared in ultrapure water and stored at -80°C. Just before use, the suspensions were sonicated for 10 min in ultrasonic bath (Elmasonic S30H). NP suspensions were observed using a JEOL1400- Figure S2 ).
Animal housing and handling

Animal housing
Male C57BL/6 mice 6-7 weeks of age were purchased from Janvier (Le Genest-St-Isle, France) and acclimated during 1 week. All mice were supplied with food (SAFE, Auguy, France) and tap sterilized water ad libitum in standard wire-topped cages in a controlled environment, with a 12 h light/dark cycle. All experiments were approved by our local Institutional Animal Care and Use Committee (Comité d'éthique -ComEth, ANSES/ENVA/UPEC, #C2EA-16).
Animal exposure to NP
To estimate the amount of NP to administrate in our study in order to be relevant for realistic occupational exposure, we utilized the following equation [17] :
Daily deposited dose of NP = occupational exposure limit (OEL) x NP mass fraction in occupational emission x minute ventilation x duration x NP deposition efficiency with 1/ OEL for welding fumes at 5 mg/m 3 , 2/ a mass concentration of NP in welding fumes at 10% of the total particle emitted 3/ a mean minute ventilation at 22.500 mL/min (tidal volume of 1500 mL and respiratory frequency of 15/min for a worker with moderate activity), 4/ a daily occupational exposure of 8 hours, and 5/ a mean deposition efficiency of NP in the alveolar region of 50% for an average NP aerodynamic diameter of 20 nm [18] [19] [20] [21] .
Importantly, these calculations do not account for particle clearance, but provide an estimate of the plausible worker exposure concentrations. Overall, the daily NP lung burden was estimated at 2.7 mg per worker per day. Given the average worker weight (70 kg) and the average weight of the mice (25 g), the daily deposited dose of NP for a mouse was estimated at 1 µg. Therefore, the dose of 5 µg weekly was considered as representative of occupational exposure of workers in the context of an unintentional process such as welding [8, 9] . The dose of 50 µg weekly was subsequently calculated for a NP only-containing aerosol, within the 5mg/m 3 OEL.
Once a week, mice received Saline (Control group), 5 or 50 µg NP (Fe 2 O 3 , Fe 3 O 4 , MnFe 2 O 4 , CrOOH groups) administrated by pharyngeal aspiration performed under anesthesia (1.6 mg ketamine (Virbac, Carros, France) plus 300 mg xylazine (Bayer®, Puteaux, France)). Mice were sacrificed as previously described 24h, 1 week, 1 or 3 months after the first exposure [22] . A schematic representation of the experimental protocol is given in Supplemental Figure   S3 . 
Lung tissue collection
Histological and immunohistochemical analysis
Paraffin-embedded lung tissue sections (5 μm) were stained with hematoxylin-eosin-saffron (HES) for histological examination or with Sirius Red for collagen deposition. The occurrence, localization and severity of histological lesions were assessed using a semiquantitative score adapted from Ashcroft [23] . At least 10 fields per lung tissue section were analyzed (magnification x200), and a scale of 4 semi-quantitative fibrosis scores was utilized:
[0: normal; 1: minimal fibrous thickening; 2: moderate thickening of walls without obvious damage to lung architecture; 3: increased fibrosis thickening of walls with definite damage to lung structure and formation of fibrous bands or small fibrous masses] for peribronchial, perivascular or alveolar wall thickness extension.
A similar scale of 4 semi-quantitative scores was used for inflammatory infiltrates in the alveolar, bronchiolar or vessel lumen, peribronchiolar or perivascular walls, as well as in the interstitium [0: < 20 inflammatory cells/field; 1: 21 to 50; 2: 51 to 100; 3: > 100]. Finally, the number of NP agglomerate/aggregate per field was also quantified (magnification x200).
Additionally, immunohistochemical (IHCh) analysis was performed using specific antibodies directed against Heme oxygenase (HO-1) protein as previously described [18] .
BALF analysis
Free alveolar cells were recovered from the lavage fluid by centrifugation at 400g for 15 min at 4 °C. The cellular pellet was suspended in 150 μL of physiological saline. An aliquot of the cell suspension was then examined using a hemocytometer to evaluate the total white cell number. For differential counts, the cell suspension was cytospun (cytospin-2, Shandon Products Ltd.), fixed in methanol, and stained with Diff Quick solution (Medion Diagnostics, Plaisir, France).
Alveolar epithelial barrier integrity and cytotoxicity evaluations
Total protein content and LDH concentrations in BALF were determined by the Bio-Rad protein assay (Bio-Rad, Marne-La-Coquette, France) and by the Cytotoxicity Detection Kit (Roche®), respectively.
Lung inflammation
In order to evaluate lung inflammation, BALF content in Transforming growth factor beta (TGFß), Tumor Necrosis Factor alpha (TNFα) and Interleukin 1beta (IL1β) proteins was quantified by DuoSet® ELISA as per the manufacturer's instructions (R&D Systems, Lille, France). Table 1S . These modifications were not present at shorter exposure durations (data not shown).
Quantification of mRNA expression in lung homogenates
Statistical analysis
Whatever the experimental condition, neither granuloma formation nor the development of emphysema could be observed. Moreover, no bronchiolar hyperplasia could be detected.
The presence of microscopically observable NP aggregates/agglomerates was not detected in 5 µg-exposed animals, but was detectable in all animals exposed to 50 µg weekly, essentially in alveolar and bronchiolar lumens, with a significantly higher number of aggregates/agglomerates present in animals weekly exposed to 50 µg MnFe 2 O 4 or CrOOH NP as compared to those exposed to Fe 2 O 3 or Fe 3 O 4 NP (Figure 3 ).
Alveolar epithelial barrier integrity
We next addressed the integrity of the epithelial barrier by assessing the total protein content and LDH release in the BALF of NP-exposed mice. As shown in Figure S4 ).
Pulmonary inflammatory and oxidative responses
As the presence of NP in the lungs has been related to the induction of inflammatory and oxidative responses [24, 25] , we next explored the total cellularity of BALF. As shown in Figure S4 , BALF total cellularity was significantly increased only in CrOOH-exposed mice as compared to unexposed animals, whatever the dose received (5 or 50 µg weekly), after a 3 months-exposure. The cell differential was kept unchanged, whatever the experimental condition; only macrophages and rare neutrophils were detected in BALF samples (data not shown).
We next evaluated the release in the BALF of NP-exposed mice, of 3 inflammatory cytokines known to represent important markers of the pulmonary response to NP exposure: TNFα, TGFß and IL1ß [24] [25] [26] . For the dose of NP relevant to welding activity (5 µg), only CrOOHexposed animals present a transient but significant increase in TNFα secretion 24 hours after the first exposure as compared to unexposed mice (Supplemental Figure S4 As for the oxidative response, no major modification of NQO1 or CYP1A1 expression could be detected in the 5 µg-exposed animals, except for a significant increase in CYP1A1 expression after 1 day of exposure to Fe 3 O 4 NP (Supplemental Figure S5 ). However, in 50 µg-exposed animals, the antioxidant NQO1 mRNA expression was significantly increased in Fe 3 O 4 -, MnFe 2 O 4 -and CrOOH-exposed mice after 1 month repeated exposure as compared to unexposed animals, and was still significantly increased after 3 months exposure duration in CrOOH-exposed mice (Figures 6 and 7) . Neither modification of CYP1A1 mRNA expression nor that of HO-1 protein was detected, whatever the experimental condition ( Figures 6, 7, 8 and Supplemental Figure S5 ).
J U S T A C C E P T E D
DISCUSSION
The general aim of our study was to investigate the pulmonary effects, in mice, of repeated exposure to NP administrated at occupationally-relevant doses. To achieve this aim, we developed an experimental protocol designed to mimic at best an occupational exposure in 2 working contexts: welding (unintentional NP production) and NP-manufacturing facility (intentional NP production).
Our results demonstrate that repeated exposure of mice to metal oxide NP at doses relevant to welding activity induce no (after Moreover, these doses were most often administrated as a single bolus, which dampens the overall relevance of the results obtained in these studies [28, 29] . Our results are therefore difficult to compare with data from the literature. However, considering the results obtained with the lowest doses used in previously published studies, the effects of weekly pulmonary exposures to Fe or Cr oxide NP can be described as limited; absence of acute inflammatory cell recruitment in the BALF in most cases, low levels of inflammatory cytokines secretion, and no histological modification after 1 month (longest time point analyzed in these studies) [26, 30-32, 33 6264 ]. Our results are in accordance with these data, and further extend them, J U S T A C C E P T E D not only to doses relevant to the occupational activity of welding, but also to longer exposure durations (up to 3 months) and to a more realistic scenario of repeated exposures instead of administration of NP as a single bolus. Interestingly, lung TNFα mRNA expression was increased in response to all NP after 3 months weekly exposure to 5 µg. Given the implication of this cytokine in the early events of inflammation, one could infer that longer exposure duration to doses of NP relevant to welding activity could lead to more pronounced lung alterations. We are fully aware that welding fumes cannot be summarized to only metal oxide NP, as a complex mixture of particles (micrometric and nanometric) together with a number of potentially toxic gases (e.g. ozone, nitrogen oxide, nitrogen dioxide) are generated during the welding process [34] . However, the relevance of our findings is supported by the fact that we were recently able to link the presence of NP aggregates/agglomerates in lung tissues samples of arc-welders to the presence of similar fibrotic lesions [18] . Various adverse outcomes have been described in welders, and are not limited to pulmonary endpoints [34] .
Therefore, although we found only limited pulmonary effects of repeated exposure to occupationally-relevant doses of metal oxide NP, extra-pulmonary adverse effects could have been detected. This could be particularly true for the brain for example, as exposure to Mn is associated with neurotoxicity in welders [34] . Moreover, an increase in the incidence of lung cancer has been described particularly in those exposed to Cr [34] . However, as the maximum exposure duration was 3 months in our study, this was probably not enough to evaluate the carcinogenicity of the exposure, even for a mouse presenting a 2.5 years life expectancy. As Mn-and Cr-based NP were the most potent to induce lung remodeling when utilized at doses relevant to welding, their extra-pulmonary effects could have been particularly interesting to evaluate. These outcomes should deserve further studies.
The mild pulmonary alterations detected at doses relevant to the occupational activity of welding were further extended both in terms of intensity and spatial distribution after repeated J U S T A C C E P T E D exposure of mice to doses relevant to the context of a NP-manufacturing facility; not only a more pronounced thickening of the peribronchial wall could be observed, but also that of perivascular and alveolar walls, together with the presence of an interstitial inflammation.
These findings were observed in response to all but Fe 2 O 3 NP, given at the same mass concentration. In an attempt to decipher the underlying molecular mechanisms of these fibrotic lesions, the expression pattern of MCP-1 mRNA in lung homogenates could be of interest, as MCP-1 expression was increased after 1 and/or 3 months of repeated exposure to 50 µg of all but Fe 2 O 3 NP. Indeed, MCP-1 is a chemokine synthetized by a large variety of cells including macrophages and fibroblasts, and which exerts chemotactic and activating effects on macrophages [35] . Moreover, it has been recently described that pulmonary fibroblast-derived MCP-1 drives fibroblast proliferation and migration in response to silicon dioxide [35] . It is also important to note that the secretion of TGFß was increased only in the BALF obtained from MnFe 2 O 4 -exposed animals during 3 months. Although we did not evaluate longer exposure durations, and given the essential role of this cytokine in the development of lung fibrosis, this result suggests that MnFe 2 O 4 -exposed animals could be particularly prone to lung remodeling, thanks to the implication of molecular mechanisms specific to this speciation of NP. This is also suggested by the fact that MnFe 2 O 4 -exposed animals develop peribronchiolar wall thickening after 3 months weekly exposure at doses relevant for welding activity. However, such remodeling was also present in animals repeatedly exposed to 5 µg CrOOH NP, which indicates the occurrence of other, yet unidentified, molecular mechanism(s) that could be responsible for lung remodeling in response to these NP.
Our data showed that Fe 2 O 3 NP were overall less reactive than Fe 3 O 4 NP. This difference could be due to different degrees of solubility between NP. However, previous data from our lab using the same metal NP as those used in the present study indicate a very small if no J U S T A C C E P T E D solubility at all whatever the NP tested [18] . Another explanation for this difference could be the different accumulation profiles between Fe 2 O 3 and Fe 3 O 4 NP. However, the number and localization of NP aggregates/agglomerates were similar for these NP, thus underlying the importance of chemical speciation in NP's effects. Interestingly, previous data from our team demonstrated that Fe 2 O 3 NP were more reactive than Fe 3 O 4 NP in terms of pro-inflammatory cytokines secretion by macrophages [18] . This suggests that macrophages might not be the essential or only target cell type to drive lung remodeling in response to iron oxide NP.
Interestingly, although aggregates/agglomerates of metal oxide NP could be detected in all groups of animals in the present study (at the 50 µg dose), yet all but Fe 2 O 3 NP were able to induce fibrotic lesions. However, the number of aggregates/agglomerates observed 3 months after repeated exposure to Fe 3 O 4 NP, which was lower than after exposure to MnFe 2 O 4 or CrOOH NP, didn't affect the intensity of the remodeling, which was similar for the 3 NP. It must be noted that, as our study was dedicated to investigate the pulmonary effects of repeated exposure to NP administrated at occupationally-relevant doses, the critical endpoint we focused on was therefore the initial mass concentration of the NP, not their size or agglomeration state immediately after sonication, i.e., just after administration to mice.
Finally, although we cannot rule out the technical difficulty of observing and characterizing such aggregates/agglomerates with a regular optical microscope, this result confirms the multifactorial origins potentially linking the presence of NP to any biological effect [36] .
Our results overall demonstrate that repeated exposure to NP at doses relevant to occupational exposure represents a potential risk for respiratory health. There is currently no international consensus regarding which OEL can be applied to NP, although they could represent a major component of the occupational pollution [37, 38] ; the proposed OEL for NP is 10% of the exposure limits established for the respective micro-scale industrial aerosols [39] . Indeed, with the exception of nanometric TiO 2 for which a recommended exposure limit (REL) at 0.3
J U S T
A C C E P T E D mg/m 3 has been proposed by the US, OEL have been defined for respirable particles only i.e. most of them in the micrometric range [37, 40, 41] . Some NP-specific values have been proposed, but they differ according to the different proposing countries or agencies, in terms of the metric used to quantify the relative exposure to NP or the categorization of NP in various risk groups, background upon which these OEL have been developed [37] , which makes these proposed values highly provisional. Moreover, the current OELs don't consider the speciation of NP, although it represents an important determinant of their biological effects.
CONCLUSION
Overall, our data demonstrate for the first time a potential risk for respiratory health posed by repeated exposure to NP at occupationally-relevant doses. Given these results, the development of OEL specifically dedicated to NP exposure might therefore be an important issue to address in the near future. 
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